Document is current

Article History

Received: 20 August 2024

Accepted: 18 October 2024

First Online: 5 November 2024

Declarations

:

: Suay G has received travel grants to attend oncology meetings from Janssen and Roche. Martín-Martorell P has received travel grants to attend oncology meetings from Roche, Astra-Zeneca and MSD. She is on speakers bureaus for Astra-Zeneca, BMS, Pfizer and Takeda, and is a PI/SI in clinical trials from Roche, Lilly, Janssen, Abbvie and Astra-Zeneca. Aparisi F has served in a consultant or advisory role for Pzifer and Boheringher Inghelheim. He has received speaker fees from Astra-Zeneca, Takeda and Sanofi, and travel expenses from Janssen, Gallecto, Pfizer, Roche, MSD and Takeda. Arnal M is on speakers bureaus for Astra-Zeneca, Roche, MSD, BMS, Pfizer, Takeda, Lilly and Janssen. Guirado M is on speakers bureaus for MSD and Takeda, and has received travel grants to attend oncology meetings from Roche. Azkárate A has received grant/research support from Astra-Zeneca and MSD, is on speakers bureaus for Astra-Zeneca, Roche, MSD, BMS, Pfizer, Takeda, Lilly and Janssen. He has received consultancy fees from Roche, Takeda, BMS and MSD, and is a PI/SI in clinical trials from Amgen, Mirati, Bayer, Takeda, Pfizer, Roche, AstraZeneca, Lilly and Janssen. Garde-Noguera J is on speakers bureaus for Astra-Zeneca, Roche, MSD, BMS, Pfizer, Takeda and Janssen. He has received grant/research support from BMS. Cumplido-Burón JD has received travel grants to attend oncology meetings from MSD. Insa A has received payment or honoraria for lectures or educational events from Astra-Zeneca, Amgen, Roche, Takeda and Pfizer. She has received support for attending meetings and/or travel expenses from Roche, Pfizer and MSD. She is on advisory boards for Astra-Zeneca, Sanofi and Pfizer. González-Muñoz JF is on Janssen’s speakers bureau. Palanca S has served in a consultant or advisory role for Roche, Astra-Zeneca, Lilly and Janssen. She has received speaker fees from Roche, Pfizer, Amgen, Astra-Zeneca, Takeda, Amgen and Lilly. She has received research funding from Roche and Astra-Zeneca, and grant support from Roche and Amgene. Díaz M has no conflicts of interest to declare. Sánchez-Hernández A is on speakers bureaus for Astra-Zeneca, Roche, MSD, BMS, Pfizer, Takeda, Lilly, Jansen, Amgen, Lilly and Novartis. She has also received consultancy fees from Roche, Takeda, BMS, MSD and Janssen. Juan-Vidal O has received honoraria or advisory role fees from Bristol-Myers Squibb, Roche/Genentech, AstraZeneca, Pfizer, Eli Lilly, Takeda and Janssen. He has received travel and accommodation grants from Takeda, Astra-Zeneca, Roche/Genentech, Pfizer and MSD.

: Ethical approval for this observational anonymized study (GIDO-2023-01) was obtained from the Clinical Research Ethical Committee from the Hospital Universitario y Politécnico La Fe of Valencia, Spain, with a favorable verdict. The Clinical Research Ethical Committee did not require an informed consent for the protocol, and an informal consent waiver was approved because the study is observational, patient data was anonymized, and the study does not include images that may identify the person.